UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:March 31,
ASLAN Pharmaceuticals (NASDAQ:ASLN)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025 Plus de graphiques de la Bourse ASLAN Pharmaceuticals
ASLAN Pharmaceuticals (NASDAQ:ASLN)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025 Plus de graphiques de la Bourse ASLAN Pharmaceuticals

Actualités Aslan Pharmaceuticals Ltd

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mercredi 17 Juillet 2024 ( il y a 8 mois) • Edgar (US Regulatory)
ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary Liquidation
Mercredi 17 Juillet 2024 ( il y a 8 mois) • GlobeNewswire Inc.
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Lundi 15 Juillet 2024 ( il y a 8 mois) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Vendredi 14 Juin 2024 ( il y a 9 mois) • Edgar (US Regulatory)
Form F-3 - Registration statement by foreign private issuers
Mercredi 12 Juin 2024 ( il y a 9 mois) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Vendredi 31 Mai 2024 ( il y a 9 mois) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Jeudi 9 Mai 2024 ( il y a 10 mois) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mardi 7 Mai 2024 ( il y a 10 mois) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Lundi 11 Mars 2024 ( il y a 12 mois) • Edgar (US Regulatory)

Plus d'articles sur Aslan Pharmaceuticals Ltd

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces